BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10926884)

  • 1. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism.
    Hustad S; Ueland PM; Vollset SE; Zhang Y; Bjørke-Monsen AL; Schneede J
    Clin Chem; 2000 Aug; 46(8 Pt 1):1065-71. PubMed ID: 10926884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.
    Jacques PF; Kalmbach R; Bagley PJ; Russo GT; Rogers G; Wilson PW; Rosenberg IH; Selhub J
    J Nutr; 2002 Feb; 132(2):283-8. PubMed ID: 11823591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype.
    Moat SJ; Ashfield-Watt PA; Powers HJ; Newcombe RG; McDowell IF
    Clin Chem; 2003 Feb; 49(2):295-302. PubMed ID: 12560354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
    Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
    Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements.
    McNulty H; McKinley MC; Wilson B; McPartlin J; Strain JJ; Weir DG; Scott JM
    Am J Clin Nutr; 2002 Aug; 76(2):436-41. PubMed ID: 12145019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
    de Jong SC; Stehouwer CD; van den Berg M; Kostense PJ; Alders D; Jakobs C; Pals G; Rauwerda JA
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism.
    Hustad S; Midttun Ø; Schneede J; Vollset SE; Grotmol T; Ueland PM
    Am J Hum Genet; 2007 May; 80(5):846-55. PubMed ID: 17436239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample.
    de Bree A; Verschuren WM; Bjørke-Monsen AL; van der Put NM; Heil SG; Trijbels FJ; Blom HJ
    Am J Clin Nutr; 2003 Mar; 77(3):687-93. PubMed ID: 12600862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline intake, plasma riboflavin, and the phosphatidylethanolamine N-methyltransferase G5465A genotype predict plasma homocysteine in folate-deplete Mexican-American men with the methylenetetrahydrofolate reductase 677TT genotype.
    Caudill MA; Dellschaft N; Solis C; Hinkis S; Ivanov AA; Nash-Barboza S; Randall KE; Jackson B; Solomita GN; Vermeylen F
    J Nutr; 2009 Apr; 139(4):727-33. PubMed ID: 19211833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
    Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the MTHFR C677T polymorphism, blood folate and vitamin B12 deficiency, and elevated serum total homocysteine in healthy individuals in Yunnan Province, China.
    Ni J; Zhang L; Zhou T; Xu WJ; Xue JL; Cao N; Wang X
    J Chin Med Assoc; 2017 Mar; 80(3):147-153. PubMed ID: 28094233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study.
    Dekou V; Whincup P; Papacosta O; Ebrahim S; Lennon L; Ueland PM; Refsum H; Humphries SE; Gudnason V
    Atherosclerosis; 2001 Feb; 154(3):659-66. PubMed ID: 11257267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
    Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.
    Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Perschl A; Vychytil A; Hörl WH; Sunder-Plassmann G
    Am J Kidney Dis; 2001 Jul; 38(1):77-84. PubMed ID: 11431185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
    Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
    Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of MTHFR 1298A-->C and MTHFR 677C-->T genotypes on total homocysteine, folate, and vitamin B(12) plasma concentrations in kdiney graft recipients.
    Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Rasoul-Rockenschaub S; Hörl WH; Sunder-Plassmann G
    J Am Soc Nephrol; 2000 Oct; 11(10):1918-1925. PubMed ID: 11004224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.